Getting the Deal Through: Navigating Antitrust Scrutiny of Health System Deals and Beyond - McDermott Will & Emery

Getting the Deal Through: Navigating Antitrust Scrutiny of Health System Deals and Beyond

Overview


According to a new report by the Health Care Cost Institute, nearly three-quarters of 112 metropolitan areas across 43 states have “highly concentrated” hospital markets—showing a rise of such areas from 67% in 2012 to 72% in 2016. And in today’s regulatory environment, this trend shows no sign of deceleration as health systems grapple with reimbursement, cost and other mission critical pressures.

This M&A activity is set against a backdrop of intensive antitrust scrutiny. The Federal Trade Commission (FTC) and often state attorneys general reviews can be challenging from a time and resource perspective. Join McDermott’s healthcare antitrust team for a webinar in which they’ll discuss and offer insight on what health systems and other industry participants can do to best position their deal for review. Topics include first-hand observations on various government practices, including:

  • Greater willingness to investigate discrete individual overlapping service lines and increasingly narrow geographic areas;
  • Growing reliance on econometric tools and economic analysis in their reviews;
  • Analytical approach toward markets where narrow and tiered networks are on the rise; and
  • Assessment of how local ACOs or CINs may factor into competitive effects analysis of a health system merger.

Dig Deeper

Miami, FL / McDermott Event / March 8-9, 2023

HPE Miami 2023

San Francisco, CA / McDermott Event / January 10, 2023

McDermott at the 2023 J.P. Morgan Healthcare Conference

Washington, D.C. / Speaking Engagements / December 12-13, 2022

Washington Health Law Summit 2022

Webinar / McDermott Event / December 6, 2022

340B ESP and HIPAA Compliance

Webinar / Speaking Engagements / November 30, 2022

Top Takeaways | ABA Antitrust Section Corporate Compliance Monthly Update

Webinar / Speaking Engagements / November 15, 2022

ABA Antitrust Section Corporate Compliance Monthly Update